Cell types we work with

Hello again, Three weeks have now passed since my first blog, and the response has been overwhelming, who knew this kid with a love of dinosaurs could become an internet blogger. Your encouragement to make my t-Rex has motivated me to do just that, so let’s see how it all goes. Also fun fact, the Read More …

Modelling diseases of the brain through stem cells

Hello SGC members and to the millions of scientific readers across the globe, My name is Thomas Durcan, and I am an assistant professor at the Montreal Neurological Institute (MNI) and McGill University, where I also lead the SGC tissue platform in Montreal. You can call me the stem cell guy, as everything I and my Read More …

Welcome to the SGC-Karolinska side of ALS-RAP: the scientists, the screening, and the antibody selections

Hello fellow scientists and open lab notebook readers! I’m Carolyn Marks and I’m working in the ALS-RAP partnership with Susanne Gräslund, who leads the Recombinant Antibodies Group at SGC-Karolinska in Stockholm, Sweden. SGC-Karolinska has had a long-standing collaboration with Helena Persson Lotsholm, Director of the Human Antibody Therapeutics Facility within the Drug Discovery and Development Read More …

Validated antibodies for ALS research: the ALS-RAP project

We are part of ALS-RAP, the ALS (Amyotrophic Lateral Sclerosis) Reproducible Antibody Platform. We’re addressing one of the big conundrums to biomedical research: the lack, or the poor quality, of many antibodies used for research ranging from cell biology to histopathology. ALS, also called MND (motor neurone disease), is a group of diseases that cause Read More …